NCT05319834View on ClinicalTrials.gov

Comparative Study Between Vaginal Progesterone Alone or Combined With Aspirin in Prevention of Recurrent Preterm Birth

PHASE4CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Preterm Birth
Interventions
DRUG

Aspirin tablet

group1: oral aspirin at a dose of 100mg once daily at the same time with progesterone

DRUG

Placebo

group 2: oral placebo once daily at the same time with progesterone

Trial Locations (1)

Unknown

Menoufia University, Shibīn al Kawm

All Listed Sponsors
lead

Menoufia University

OTHER